Novan announces full top line results from phase 2 molluscum contagiosum clinical trial
Novan announced full top line results from the Company’s Phase 2 clinical trial to evaluate topical nitric oxide product candidate SB206 for treatment of molluscum contagiosum. Results demonstrated a clear treatment effect on the complete clearance of all molluscum lesions at Week 12. December 10, 2018